Relationship between the 4Ts scoring system and the antiplatelet factor 4/heparin antibodies test in critically ill patients

作者: Yosuke Matsumura , Taka-aki Nakada , Shigeto Oda

DOI: 10.1002/AMS2.15

关键词:

摘要: Aim Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction and potentially progresses to fatal thrombosis. The 4Ts scoring system has been reported as a clinical pretest for HIT. However, its usefulness in critically ill patients not yet thoroughly examined. Thus, we evaluated the of score diagnosis HIT patients. Methods One hundred four who were admitted our intensive care unit underwent antiplatelet factor 4/heparin complex antibodies (PF4/heparin Ab) test with suspected enrolled study. primary endpoint variable was score. secondary variables laboratory data, length stay, mortality, compared between thePF4/heparin Ab positive negative groups. Results There no significant difference scores PF4/heparin groups. predictive value (HIT patients/4T high patients) 15.4% (2/13), (non-HIT low 87.5% (42/48), false-negative rate (4T patients/HIT 54.5% (6/11). had longer stay (P = 0.035). Conclusions The present study showed discrepancy Ab. When patients, immediate antibody initiation therapeutic management are required regardless

参考文章(37)
Nancy M Heddle, Theodore E Warkentin, Laboratory diagnosis of immune heparin-induced thrombocytopenia. Current hematology reports. ,vol. 2, pp. 148- ,(2003)
Theodore E Warkentin, Beng H Chong, Andreas Greinacher, None, Heparin-induced thrombocytopenia: towards consensus. Thrombosis and Haemostasis. ,vol. 79, pp. 1- 7 ,(1998) , 10.1055/S-0037-1614206
Elise M Gettings, Kathryn A Brush, Elizabeth M Van Cott, William E Hurford, Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study Critical Care. ,vol. 10, pp. 1- 7 ,(2006) , 10.1186/CC5100
Yves Gruel, Claire Pouplard, Dominique Lasne, Charlotte Magdelaine-Beuzelin, Chloé Charroing, Hervé Watier, The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes Blood. ,vol. 104, pp. 2791- 2793 ,(2004) , 10.1182/BLOOD-2004-01-0058
Adam Cuker, Phyllis A. Gimotty, Mark A. Crowther, Theodore E. Warkentin, Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis Blood. ,vol. 120, pp. 4160- 4167 ,(2012) , 10.1182/BLOOD-2012-07-443051
Lena M. Napolitano, Theodore E. Warkentin, Amjad AlMahameed, Stanley A. Nasraway, Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^ Critical Care Medicine. ,vol. 34, pp. 2898- 2911 ,(2006) , 10.1097/01.CCM.0000248723.18068.90
Arun K. Verma, Marc Levine, Stephen J. Shalansky, Cedric J. Carter, John G. Kelton, Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy. ,vol. 23, pp. 745- 753 ,(2003) , 10.1592/PHCO.23.6.745.32188
Barbara Denys, Veronique Stove, Jan Philippé, Katrien Devreese, A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia Thrombosis Research. ,vol. 123, pp. 137- 145 ,(2008) , 10.1016/J.THROMRES.2008.04.020
M. Carrier, M.A. Rodger, D. Fergusson, S. Doucette, M.J. Kovacs, J. Moore, J.G. Kelton, G.A. Knoll, Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex Kidney International. ,vol. 73, pp. 213- 219 ,(2008) , 10.1038/SJ.KI.5002631
Scarparo Pamela, Lombardi Anna Maria, Duner Elena, Malerba Giovanni, Allemand Emanuele, Vettore Silvia, Blumentritt Carmen, Greinacher Andreas, Fabris Fabrizio, Heparin-induced thrombocytopenia: The role of platelets genetic polymorphisms Platelets. ,vol. 24, pp. 362- 368 ,(2013) , 10.3109/09537104.2012.701026